Company Profile

Gradient Medical Inc
Profile last edited on: 9/29/2022      CAGE: 8PTM2      UEI: HPZ7FS9MF8J1

Business Identifier: Novel interventional oncology therapies: pulsed electric field therapies
Year Founded
2020
First Award
2021
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

150 Fayetteville Street Suite 300
Raleigh, NC 27601
   (512) 680-8332
   N/A
   www.gradient-medical.com
Location: Single
Congr. District: 13
County: Wake

Public Profile

Gradient Medical develops interventional oncology solutions and services with a focus on bringing ACE therapy to clinics. The firm's ACE (Algorithmically Controlled Electroporation) therapy delivers electrical pulses that target cancer cells and disrupt biological functions while offering real time sensing to give clinicians control over the treatment zone and maximize therapeutic effectiveness and minimize treatment times. This solution enables clinicians to treat inoperable tumors near critical structures, treating the precise size and shape needed. Algorithmically Controlled Electroporation offers a closed loop temperature regulated pulsed electric field cancer ablation through the creation of a 3D tumor model that enables evaluation of specific treatment parameters at physiological temperatures that is not possible with other systems such as open-loop.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Key People / Management

  Michael Sano -- Founder and CEO

  Matthew DeWitt -- Director of Research & Development